Banque Cantonale Vaudoise Buys 146 Shares of Teleflex Incorporated (NYSE:TFX)

Banque Cantonale Vaudoise increased its stake in Teleflex Incorporated (NYSE:TFX) by 184.8% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 225 shares of the medical technology company’s stock after acquiring an additional 146 shares during the quarter. Banque Cantonale Vaudoise’s holdings in Teleflex were worth $56,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of TFX. Janus Henderson Group PLC increased its stake in shares of Teleflex by 12.0% in the 1st quarter. Janus Henderson Group PLC now owns 5,409,317 shares of the medical technology company’s stock valued at $1,223,424,000 after acquiring an additional 581,312 shares in the last quarter. Point72 Asset Management L.P. lifted its holdings in shares of Teleflex by 564.3% in the 2nd quarter. Point72 Asset Management L.P. now owns 310,484 shares of the medical technology company’s stock worth $65,304,000 after purchasing an additional 263,743 shares in the last quarter. Cooke & Bieler LP lifted its holdings in shares of Teleflex by 23.3% in the 2nd quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company’s stock worth $191,989,000 after purchasing an additional 172,335 shares in the last quarter. Ceredex Value Advisors LLC bought a new position in shares of Teleflex in the 2nd quarter worth $25,550,000. Finally, National Bank of Canada FI lifted its holdings in shares of Teleflex by 1,008.2% in the 2nd quarter. National Bank of Canada FI now owns 115,343 shares of the medical technology company’s stock worth $24,388,000 after purchasing an additional 104,935 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Stock Up 0.6 %

TFX stock opened at $191.71 on Friday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The stock’s fifty day simple moving average is $224.99 and its two-hundred day simple moving average is $222.73. Teleflex Incorporated has a 1-year low of $185.66 and a 1-year high of $257.85. The stock has a market cap of $8.90 billion, a P/E ratio of 38.11, a P/E/G ratio of 1.95 and a beta of 1.18.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.38 by $0.11. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $764.40 million during the quarter, compared to the consensus estimate of $768.68 million. During the same period last year, the business posted $3.64 earnings per share. The business’s revenue for the quarter was up 2.4% on a year-over-year basis. Analysts expect that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.71%. The ex-dividend date is Friday, November 15th. Teleflex’s dividend payout ratio (DPR) is presently 27.04%.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on TFX. Truist Financial reiterated a “hold” rating and issued a $227.00 target price (down from $255.00) on shares of Teleflex in a report on Monday, November 4th. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a report on Friday, November 1st. Mizuho lowered their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. Stephens increased their price target on Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a research report on Friday, August 2nd. Finally, Royal Bank of Canada lowered their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Four research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $259.25.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.